Page last updated: 2024-09-04

moxifloxacin and Diarrhea

moxifloxacin has been researched along with Diarrhea in 13 studies

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (38.46)29.6817
2010's8 (61.54)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, YB; Fang, YH; Gu, SL; Li, LJ; Lv, T; Shen, P; Tang, LL1
Caminero Luna, JA; Cerezo Lajas, A; de Miguel Díez, J; Rodríguez Guzmán, MDC1
Forbes, BA; Gerding, DN; Goldstein, EJ; Jacobus, NV; Jenkins, SG; Johnson, S; McDermott, LA; Mirrett, S; Patel, R; Snydman, DR; Stone, S; Thorpe, C1
del Mar Gamboa-Coronado, M; López-Ureña, D; Montoya-Ramírez, M; Quesada-Gómez, C; Rodríguez, C; Rodríguez-Cavallini, E; Somogyi, T1
Abratt, V; Kullin, B; Reid, SJ; Wojno, J1
Simoens, S1
Carman, RJ; Genheimer, CW; Hiltonsmith, MF; Lyerly, DM; Park, M; Rafii, F1
Baral, RM; Gottlieb, S; Govendir, M; Hansen, T; Kimble, B; Malik, R; Norris, JM; Wigney, DI1
Kang, JO; Kim, J; Pai, H; Seo, MR1
Farina, C; Russello, G; Russo, A; Scaltrito, MM; Sisto, F1
López, R; Ortiz-de-Saracho, J; Pantoja, L; Romero, MJ1
Carroll, DN1
Gottlieb, T; Leroi, MJ; Siarakas, S1

Reviews

1 review(s) available for moxifloxacin and Diarrhea

ArticleYear
Evidence for moxifloxacin in community-acquired pneumonia: the impact of pharmaco-economic considerations on guidelines.
    Current medical research and opinion, 2009, Volume: 25, Issue:10

    Topics: Anti-Bacterial Agents; Aza Compounds; Clostridioides difficile; Clostridium Infections; Community-Acquired Infections; Cost-Benefit Analysis; Diarrhea; Drug Resistance, Microbial; Economics, Pharmaceutical; Fluoroquinolones; Humans; Moxifloxacin; Pneumonia, Bacterial; Practice Guidelines as Topic; Quinolines

2009

Other Studies

12 other study(ies) available for moxifloxacin and Diarrhea

ArticleYear
Molecular epidemiology and antimicrobial susceptibility of Clostridium difficile isolated from hospitals during a 4-year period in China.
    Journal of medical microbiology, 2018, Volume: 67, Issue:1

    Topics: Anti-Infective Agents; Bacterial Proteins; China; Clindamycin; Clostridioides difficile; Clostridium Infections; Diarrhea; Drug Resistance, Multiple, Bacterial; Erythromycin; Fluoroquinolones; Humans; Metronidazole; Microbial Sensitivity Tests; Molecular Epidemiology; Moxifloxacin; Tertiary Care Centers; Vancomycin

2018
Antituberculosis Treatment in a Patient with Celiac Disease.
    Archivos de bronconeumologia, 2018, Volume: 54, Issue:6

    Topics: Aged; Antitubercular Agents; Celiac Disease; Diarrhea; Diet, Gluten-Free; Drug Compounding; Drug Substitution; Drug Therapy, Combination; Ethambutol; Glutens; Hemoptysis; Humans; Isoniazid; Male; Metronidazole; Moxifloxacin; Pyrazinamide; Rifampin; Smoking; Tomography, X-Ray Computed; Tuberculosis, Pulmonary

2018
U.S.-Based National Sentinel Surveillance Study for the Epidemiology of Clostridium difficile-Associated Diarrheal Isolates and Their Susceptibility to Fidaxomicin.
    Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:10

    Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Toxins; Clindamycin; Clostridioides difficile; Diarrhea; Drug Resistance, Bacterial; Enterocolitis, Pseudomembranous; Fidaxomicin; Fluoroquinolones; Genes, Bacterial; Humans; Metronidazole; Microbial Sensitivity Tests; Moxifloxacin; Multiplex Polymerase Chain Reaction; Prohibitins; Sentinel Surveillance; United States; Vancomycin

2015
Predominance and high antibiotic resistance of the emerging Clostridium difficile genotypes NAPCR1 and NAP9 in a Costa Rican hospital over a 2-year period without outbreaks.
    Emerging microbes & infections, 2016, May-11, Volume: 5

    Topics: Anti-Bacterial Agents; Clindamycin; Clostridioides difficile; Clostridium Infections; Communicable Diseases, Emerging; Costa Rica; Cross Infection; Diarrhea; Disease Outbreaks; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterocolitis, Pseudomembranous; Fluoroquinolones; Genes, Bacterial; Genotype; Hospitals; Humans; Microbial Sensitivity Tests; Molecular Typing; Moxifloxacin; Ribotyping; Time Factors; Vancomycin

2016
Toxin A-negative toxin B-positive ribotype 017 Clostridium difficile is the dominant strain type in patients with diarrhoea attending tuberculosis hospitals in Cape Town, South Africa.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2017, Volume: 36, Issue:1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; Child; Child, Preschool; Clostridioides difficile; Clostridium Infections; Diarrhea; Disk Diffusion Antimicrobial Tests; Enterotoxins; Erythromycin; Female; Fluoroquinolones; Hospitals, Chronic Disease; Humans; Infant; Infant, Newborn; Male; Middle Aged; Minisatellite Repeats; Molecular Epidemiology; Moxifloxacin; Ribotyping; Rifampin; South Africa; Young Adult

2017
Diversity of moxifloxacin resistance during a nosocomial outbreak of a predominantly ribotype ARU 027 Clostridium difficile diarrhea.
    Anaerobe, 2009, Volume: 15, Issue:6

    Topics: Anti-Bacterial Agents; Aza Compounds; Clostridioides difficile; Cross Infection; Diarrhea; Disease Outbreaks; DNA Gyrase; Drug Resistance, Bacterial; Enterocolitis, Pseudomembranous; Fluoroquinolones; Genetic Variation; Humans; Microbial Sensitivity Tests; Moxifloxacin; Mutation; Polymerase Chain Reaction; Quinolines; Ribotyping

2009
Susceptibility of rapidly growing mycobacteria isolated from cats and dogs, to ciprofloxacin, enrofloxacin and moxifloxacin.
    Veterinary microbiology, 2011, Jan-10, Volume: 147, Issue:1-2

    Topics: Animals; Anti-Bacterial Agents; Australia; Aza Compounds; Cats; Ciprofloxacin; Diarrhea; Dogs; Enrofloxacin; Female; Fluoroquinolones; Male; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium; Quinolines

2011
Clinical and microbiologic characteristics of tcdA-negative variant Clostridium difficile infections.
    BMC infectious diseases, 2012, May-09, Volume: 12

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Aza Compounds; Bacterial Proteins; Bacterial Toxins; Clindamycin; Clostridioides difficile; Clostridium Infections; Diarrhea; Drug Resistance, Microbial; Enterotoxins; Feces; Female; Fluoroquinolones; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Prospective Studies; Quinolines; Risk Factors; Severity of Illness Index; Treatment Outcome

2012
Laboratory diagnosis of Clostridium difficile associated diarrhoea and molecular characterization of clinical isolates.
    The new microbiologica, 2012, Volume: 35, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Algorithms; Aza Compounds; Bacterial Proteins; Bacterial Toxins; Clostridioides difficile; Clostridium Infections; Diarrhea; Drug Resistance, Bacterial; Enterotoxins; Feces; Female; Fluoroquinolones; Genes, Bacterial; Glutamate Dehydrogenase; Humans; Immunoenzyme Techniques; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Prevalence; Quinolines; Ribotyping; Sensitivity and Specificity; Young Adult

2012
Moxifloxacin-induced Clostridium difficile diarrhea.
    The Annals of pharmacotherapy, 2003, Volume: 37, Issue:3

    Topics: Adult; Anti-Infective Agents; Aza Compounds; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Female; Fluoroquinolones; Humans; Moxifloxacin; Quinolines

2003
Moxifloxacin-induced Clostridium difficile-associated diarrhea.
    Pharmacotherapy, 2003, Volume: 23, Issue:11

    Topics: Adult; Aza Compounds; Clostridioides difficile; Diarrhea; Female; Fluoroquinolones; Humans; Moxifloxacin; Quinolines

2003
E test susceptibility testing of nosocomial Clostridium difficile isolates against metronidazole, vancomycin, fusidic acid and the novel agents moxifloxacin, gatifloxacin, and linezolid.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2002, Volume: 21, Issue:1

    Topics: Acetamides; Anti-Infective Agents; Aza Compounds; Clostridioides difficile; Clostridium Infections; Cross Infection; Diarrhea; Fluoroquinolones; Fusidic Acid; Gatifloxacin; Humans; Linezolid; Metronidazole; Microbial Sensitivity Tests; Moxifloxacin; Oxazolidinones; Quinolines; Sensitivity and Specificity; Vancomycin

2002